Inflammatory bowel disease patients provide reliable self‐reported medical information: A multicentre prospective pharmacovigilance monitoring system
Pepijn W. A. Thomas(Radboud University Nijmegen), Frank Hoentjen(Radboud University Nijmegen), Naomi T. Jessurun(Netherlands Pharmacovigilance Centre Lareb), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Rachel West(Sint Franciscus Gasthuis), Jeroen M. Jansen(OLVG), Leanne J. Kosse(Netherlands Pharmacovigilance Centre Lareb), Maurice G. Rüssel(Medisch Spectrum Twente)
Cited by 10
Related Papers
Endoscopic or surgical step-up approach for infected necrotising pancreatitis: a multicentre randomised trial
|The Lancet|2017|732
Immediate versus Postponed Intervention for Infected Necrotizing Pancreatitis
|New England Journal of Medicine|2021|269
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
|Nature Communications|2018|252
Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis
|Gastroenterology|2020|233
Reduction of Colitis by Prebiotics in HLA-B27 Transgenic Rats Is Associated with Microflora Changes and Immunomodulation
|Inflammatory Bowel Diseases|2005|215